Your browser doesn't support javascript.
loading
Causal relationship between particulate matter 2.5 and infectious diseases: A two-sample Mendelian randomization study.
Zeng, Youjie; Pang, Ke; Cao, Si; Lin, Guoxin; Tang, Juan.
Affiliation
  • Zeng Y; Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
  • Pang K; Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
  • Cao S; Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
  • Lin G; Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
  • Tang J; Department of Nephrology, Third Xiangya Hospital, Central South University, Critical Kidney Disease Research Center of Central South University, Changsha, 410013, China.
Heliyon ; 10(1): e23412, 2024 Jan 15.
Article in En | MEDLINE | ID: mdl-38163134
ABSTRACT

Background:

Previous observational studies suggested a correlation between particulate matter 2.5 (PM2.5) and infectious diseases, but causality remained uncertain. This study utilized Mendelian randomization (MR) analysis to investigate causal relationships between PM2.5 concentrations and various infectious diseases (COVID-19 infection, hospitalized COVID-19, very severe COVID-19, urinary tract infection, bacterial pneumonia, and intestinal infection).

Methods:

Inverse variance weighted (IVW) was the primary method for evaluating causal associations. For significant causal estimates, multiple sensitivity tests were further performed (i) three additional MR methods (MR-Egger, weighted median, and maximum likelihood method) for supplementing IVW; (ii) Cochrane's Q test for assessing heterogeneity; (iii) MR-Egger intercept test and MR-PRESSO global test for evaluating horizontal pleiotropy; (iv) leave-one-out sensitivity test for determining the stability.

Results:

PM2.5 concentration significantly increased the risk of hospitalized COVID-19 (OR = 1.91, 95 % CI 1.06-3.45, P = 0.032) and very severe COVID-19 (OR = 3.29, 95 % CI 1.48-7.35, P = 3.62E-03). However, no causal effect was identified for PM2.5 concentration on other infectious diseases (P > 0.05). Furthermore, various sensitivity tests demonstrated the reliability of significant causal relationships.

Conclusions:

Overall, lifetime elevated PM2.5 concentration increases the risk of hospitalized COVID-19 and very severe COVID-19. Therefore, controlling air pollution may help mitigate COVID-19 progression.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Heliyon Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Heliyon Year: 2024 Type: Article Affiliation country: China